Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy-Reference-Cited by-同舟云学术

Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy

Published:1999-04 Issue:4 Volume:35 Page:549-557
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Buske C,Feuring-Buske M,Unterhalt M,Hiddemann W

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference99 articles.

1. Recent cancer trends in the United States;Devesa;J. Natl. Cancer Inst.,1995

2. Non-Hodgkin’s lymphoma time trends. United States and international data;DeVesa;Cancer Res.,1992

3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Non-Hodgkin’s lymphoma (ICD9 200, 202) in trends in cancer incidence and mortality, 1993. IARC Publication no. 121, Lyon, 1993, 641–653.

4. Cancer statistics;Parker;CA Cancer Journal for Clinicians,1996

5. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group;Harris;Blood,1994

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab;Rheumatology;2011

2. Liposomes, Dendrimers and other Polymeric Nanoparticles for Targeted Delivery of Anticancer Agents - A Comparative Study;Nanotechnologies for the Life Sciences;2007-09-15

3. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab′)2 fragment via induction of apoptosis;Cancer Letters;2004-03-18

4. Tumor-Directed Targeting of Liposomes;Bioscience Reports;2002-04-01

5. Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab;Experimental Hematology;2001-12